Order Article Reprints

Kuo W-L, Tseng L-L, Chang C-C, Chen C-J, Cheng M-L, Cheng H-H, Wu M-J, Chen Y-L, Chang R-T, Tang H-Y, et al. Prognostic Significance of O-GlcNAc and PKM2 in Hormone Receptor-Positive and HER2-Nonenriched Breast Cancer. Diagnostics. 2021; 11(8):1460. https://doi.org/10.3390/diagnostics11081460

Kuo, Wen-Ling, Lin-Lu Tseng, Che-Chang Chang, Chih-Jung Chen, Mei-Ling Cheng, Hsin-Hung Cheng, Meng-Jen Wu, Yu-Lun Chen, Ruei-Ting Chang, Hsiang-Yu Tang, and et al. 2021. "Prognostic Significance of O-GlcNAc and PKM2 in Hormone Receptor-Positive and HER2-Nonenriched Breast Cancer" Diagnostics 11, no. 8: 1460. https://doi.org/10.3390/diagnostics11081460

Kuo, W.-L., Tseng, L.-L., Chang, C.-C., Chen, C.-J., Cheng, M.-L., Cheng, H.-H., Wu, M.-J., Chen, Y.-L., Chang, R.-T., Tang, H.-Y., Hsu, Y.-C., Lin, W.-J., Kao, C.-Y., Hsieh, W.-P., Kung, H.-J., & Wang, W.-C. (2021). Prognostic Significance of O-GlcNAc and PKM2 in Hormone Receptor-Positive and HER2-Nonenriched Breast Cancer. Diagnostics, 11(8), 1460. https://doi.org/10.3390/diagnostics11081460